Controlling Mania with Anticonvulsants
cont. from
Not all patients with symptoms of mania benefit from lithium. Some have been
found to respond to another type of medication, the anticonvulsant medications
that are usually used to treat epilepsy.
Carbamazepine (Tegretol) is the
anticonvulsant that has been most widely used. Individuals with bipolar disorder
who cycle rapidly, (changing from mania to depression and back again over the
course of hours or days, rather than months) seem to respond particularly well
to carbamazepine.
Early side effects of carbamazepine, although generally mild, include
drowsiness, dizziness, confusion, disturbed vision, perceptual distortions,
memory impairment, and nausea. They are usually transient and often respond to
temporary dosage reduction. Another common but generally mild adverse effect is
the lowering of the white blood cell count which requires periodic blood tests
to monitor against the rare possibility of more serious, even life-threatening,
bone marrow depression. Also serious are the skin rashes that can occur in 15 to
20 percent of patients. These rashes are sometimes severe enough to require
discontinuation of the medication.
In 1995, the anticonvulsant divalproex sodium (Depakote) was approved by the
Food and Drug Administration for manic-depressive illness. Clinical trials have
shown it to have an effectiveness in controlling manic symptoms equivalent to
that of lithium; it is effective in both rapid-cycling and non-rapid-cycling
bipolar.
Though divalproex can cause gastrointestinal side effects, the incidence is
low. Other adverse effects occasionally reported are headache, double vision,
dizziness, anxiety, or confusion. Because in some cases divalproex has caused
liver dysfunction, liver function tests should be performed prior to therapy and
at frequent intervals thereafter, particularly during the first six months of
therapy.
next: Medication Precautions With Children, the Elderly and Women
top .
pages 1 2 .
send to friend .
bipolar site
map
Reviewed: 03/2006
|
|